Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bronchiectasis Research Registry

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2016 by COPD Foundation
Sponsor:
Information provided by (Responsible Party):
COPD Foundation
ClinicalTrials.gov Identifier:
NCT01822834
First received: March 28, 2013
Last updated: July 25, 2016
Last verified: July 2016
  Purpose
The Bronchiectasis Research Registry is a consolidated database of non-cystic fibrosis (non-CF) Bronchiectasis and Nontuberculosis Mycobacteria (NTM) patients from multiple clinical institutions.

Condition
Non-CF Bronchiectasis
Nontuberculosis Mycobacteria (NTM)

Study Type: Observational [Patient Registry]
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 20 Years

Resource links provided by NLM:


Further study details as provided by COPD Foundation:

Primary Outcome Measures:
  • Patient Recruitment and Data analysis [ Time Frame: December 2050 ] [ Designated as safety issue: No ]
    The COPD Foundation expects to assist at least 4 researchers (with patient recruitment and/or data analysis) annually.


Estimated Enrollment: 5000
Study Start Date: January 2008
Estimated Primary Completion Date: December 2050 (Final data collection date for primary outcome measure)
Groups/Cohorts
Non-CF Bronchiectasis Patients with or without NTM
Patients over the age of 18 with non-CF Bronchiectasis with or without Nontuberculosis Mycobacteria (NTM).
Nontuberculosis Mycobacteria (NTM)
Patients over the age of 18 with Nontuberculosis Mycobacteria (NTM)

Detailed Description:
The Bronchiectasis Research Registry is a consolidated database of non-cystic fibrosis (non-CF) Bronchiectasis and Nontuberculosis Mycobacteria (NTM) patients from multiple clinical institutions. The goal of the Bronchiectasis Research Registry is to support collaborative research and assist in the planning of multi-center clinical trials for the treatment of NTM and non-CF Bronchiectasis, a progressive, non-curable disease of the lungs, which afflicts thousands of patients. The Registry will also be used to provide better insight into the study of the different types of Bronchiectasis, as well as the pathophysiology of the disorder. In 2012, in collaboration with NTM Info and Research, Inc (NTMir) and the consortium members, the COPD Foundation expanded the Bronchiectasis Research Registry to enroll patients with "non tuberculous mycobacteria (NTM) only". Prior to this time, the registry included individuals with Bronchiectasis, with or without NTM.
  Eligibility

Ages Eligible for Study:   18 Years to 120 Years   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Patients over the age of 18 with non-CF Bronchiectasis and/or Nontuberculosis Mycobacteria (NTM).
Criteria

Inclusion Criteria:

  • Over the age of 18
  • non-CF Bronchiectasis
  • Nontuberculosis Mycobacteria (NTM)

Exclusion Criteria:

  • Under the age of 18
  • CF Bronchiectasis
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01822834

Contacts
Contact: Elisha Malanga 1-866-731-2673 ext 309

Locations
United States, District of Columbia
COPD Foundation Recruiting
Washington, District of Columbia, United States
Sponsors and Collaborators
COPD Foundation
  More Information

Responsible Party: COPD Foundation
ClinicalTrials.gov Identifier: NCT01822834     History of Changes
Other Study ID Numbers: BRR 
Study First Received: March 28, 2013
Last Updated: July 25, 2016
Health Authority: United States: Western Institutional Review Board

Additional relevant MeSH terms:
Bronchiectasis
Mycobacterium Infections
Bronchial Diseases
Respiratory Tract Diseases
Actinomycetales Infections
Gram-Positive Bacterial Infections
Bacterial Infections

ClinicalTrials.gov processed this record on September 30, 2016